NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Oakland, Calif., where Elon Musk’s trial against OpenAI and its chief executive, Sam Altman, starts on Monday, is not exactly known as a hub of the tech industry.Read More